Clinical Characteristics and Outcome of Patients with EZH2- Mutant Myelodysplastic Syndromes

被引：0

作者：

Ball, Somedeb ^{[1
]}

Aguirre, Luis E. E. ^{[1
]}

Jain, Akriti G. ^{[1
]}

Hussaini, Mohammad O. ^{[2
]}

Al Ali, Najla ^{[3
]}

Tinsley-Vance, Sara Marie ^{[1
]}

Chan, Onyee ^{[4
]}

Kuykendall, Andrew T. ^{[1
]}

Sweet, Kendra ^{[1
]}

Lancet, Jeffrey E. ^{[1
]}

Sallman, David A. ^{[5
]}

Padron, Eric ^{[1
]}

Komrokji, Rami S. ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematopathol & Lab Med, Tampa, FL USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[4] Dept Malignant Hematol, Tampa, FL USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-153465

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1531

引用

页数：4

共 50 条

[21] Biologic characteristics of 164 patients with myelodysplastic syndromes
Reza, S
Dar, S
Andric, T
Qawi, H
Mundle, S
Shetty, V
Venugopal, P
Ali, I
Lisak, L
Raza, A
LEUKEMIA & LYMPHOMA, 1999, 33 (3-4) : 281 - 287
[22] Biologic characteristics of patients with hypocellular myelodysplastic syndromes
Goyal, R
Qawi, H
Ali, I
Dar, S
Mundle, S
Shetty, V
Mativi, Y
Allampallam, K
Lisak, L
Loew, J
Venugopal, P
Gezer, S
Robin, E
Rifkin, S
Raza, A
LEUKEMIA RESEARCH, 1999, 23 (04) : 357 - 364
[23] The Impact of Comorbidities on Clinical Outcome of Patients with Myelodysplastic Syndromes: A Real-Life Survey
Balleari, Enrico
Salvetti, Chiara
Bacigalupo, Andrea
Forni, Gianluca
Gobbi, Marco
Ghio, Riccardo
Scudeletti, Marco
Tassara, Rodolfo
Berisso, Giovanni
Calzamiglia, Tullio
Arboscello, Eleonora
Beltrami, Germana
Bergamaschi, Micaela
Cavalleri, Maurizio
Del Corso, Lisette
Favorini, Serena
Filiberti, Rosa
Goretti, Riccardo
Miglino, Maurizio
Mitschoning, Laura
Molinari, Elisa
Racchi, Omar
Clavio, Marino
BLOOD, 2014, 124 (21)
[24] Outcome of patients with myelodysplastic syndromes in the Veterans Administration population
Komrokji, Rami S.
Matacia-Murphy, Gina M.
Al Ali, Najla H.
Beg, M. S.
Safa, Malek M.
Rollison, Dana E.
List, Alan F.
LEUKEMIA RESEARCH, 2010, 34 (01) : 59 - 62
[25] CLINICAL AND CYTOGENETIC CHARACTERISTICS OF MYELODYSPLASTIC SYNDROMES DEVELOPING MYELOFIBROSIS
OHYASHIKI, K
SASAO, I
OHYASHIKI, JH
MURAKAMI, T
IWABUCHI, A
TAUCHI, T
SAITO, M
NAKAZAWA, S
SERIZAWA, H
EBIHARA, Y
TOYAMA, K
CANCER, 1991, 68 (01) : 178 - 183
[26] Genomic and Clinical Heterogeneity in TP53 Mutant Myelodysplastic Syndromes
Coty-Fattal, Zachary
Sukhanova, Madina
Lu, Xinyan
Wolniak, Kristy
Gao, Juehua
Behdad, Amir
LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 934 - 935
[27] SOCIODEMOGRAPHIC AND CLINICAL PROFILE OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Ferreira, Marcos Antonio, Jr.
Ivo, Maria Lucia
Jardim Cury Pontes, Elenir Rose
de Souza Rego Pinto Carvalho, Diana Paula
Vitor, Allyne Fortes
BIOSCIENCE JOURNAL, 2014, 30 (04): : 1269 - 1277
[28] Clinical features and prognosis of patients with myelodysplastic syndromes
Germing, Ulrich
Strupp, Corinna
Giagounidis, Aristoteles
CANCER TREATMENT REVIEWS, 2007, 33 : S15 - S18
[29] Genomic and Clinical Heterogeneity in TP53 Mutant Myelodysplastic Syndromes
Coty-Fattal, Zachary
Sukhanova, Madina
Lu, Xinyan
Wolniak, Kristy
Gao, Juehua
Behdad, Amir
MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 934 - 935
[30] Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Gorica Nikoloski
Saskia M C Langemeijer
Roland P Kuiper
Ruth Knops
Marion Massop
Evelyn R L T M Tönnissen
Adrian van der Heijden
Theresia N Scheele
Peter Vandenberghe
Theo de Witte
Bert A van der Reijden
Joop H Jansen
Nature Genetics, 2010, 42 : 665 - 667

← 1 2 3 4 5 →